pharmacokinetic blood sampling

PROCEDURE2 trials

Sponsors

University of Michigan

Conditions

Critically Ill Renal Failure Requiring CVVHD and OseltamivirCritically Ill Requiring ECMO and OseltamivirEnd-Stage Renal DiseaseStage 5 Chronic Kidney Disease

Phase 4

Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)

CompletedNCT01048879

University of MichiganCritically Ill Renal Failure Requiring CVVHD and Oseltamivir, Critically Ill Requiring ECMO and Oseltamivir

Start: 2009-10-31End: 2010-01-31Updated: 2012-08-21

Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5

CompletedNCT02392208

University of MichiganEnd-Stage Renal Disease, Stage 5 Chronic Kidney Disease

Start: 2015-07-31End: 2016-03-31Updated: 2017-04-04

Related Papers

Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysis

Journal of Antimicrobial Chemotherapy2021-09-173 citations